Drug intelligence / Profile preview

NVP-1905

Development stage: Unknown
Lead developer: NVP Healthcare
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

NVP-1905 is a probiotic health functional food ingredient developed by NVP Healthcare (also known as Navipharm) for the management of menopausal symptoms in women. The product is based on the specific probiotic strain *Lactobacillus plantarum* NVP1701. It has received approval from the South Korean Ministry of Food and Drug Safety (MFDS) as an "individually recognized functional ingredient," a regulatory status granted to substances with proven efficacy for specific health claims. NVP-1905 is designed to alleviate common menopausal issues, such as hot flashes, night sweats, and sleep disturbances, by modulating the gut microbiota and influencing the gut-brain-skin axis. Clinical research associated with the NVP1701 strain suggests it may help balance hormonal fluctuations and reduce systemic inflammation during the menopausal transition.

Other names: Lactobacillus plantarum NVP1701

Beyond the preview

Go deeper on NVP-1905.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NVP-1905.

Explore the full profile